Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Gregory Parkhurst, AAO 2022: I can’t have LASIK … Now what? Transitioning to implantable collamer lens

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 20th 2022

In this touchOPHTHALMOLOGY interview, Dr Gregory Parkhurst (Parkhurst NuVision, San Antonio, TX, US) discusses his AAO 2022 presentation about transitioning patients from LASIK eye surgery to implantable collamer lens. 

‘I Can’t Have LASIK … Now What? Transitioning to ICL’ was presented at the annual American Academy of Ophthalmology (AAO) meeting, 30 September – 3 October 2022 

  1. What factors affect the choice between LASIK and implantable collamer lens (ICL)? (00:18)
  2. What is the best method to transition a patient from LASIK to an ICL? (02:59)

Disclosure: Dr Gregory Parkhurst is a consultant for and receives grant/research support from Staar Surgical.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed as a highlight of AAO 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup